MedTrace Logo

Resistant Bacteria in Children in France

NCT06036628 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 306

Last updated 2026-03-19

No results posted yet for this study

Summary

This study is observational, multicenter and prospective study for surveillance of the use of new antibiotics in pediatrics for treated pediatrics infections due to multi-resistant bacteria

Conditions

  • Infection Due to Resistant Bacteria
  • Multi-antibiotic Resistance
  • Antibiotic Prescription
  • Risk Factors
  • Healing
  • Complications
  • Intensive Care Unit
  • Hospital Discharge
  • Outcome, Fatal

Sponsors & Collaborators

  • Pfizer

    collaborator INDUSTRY

  • Association Clinique Thérapeutique Infantile du val de Marne

    lead OTHER

Principal Investigators

  • Levy Corinne · Association Clinique Thérapeutique Infantile du val de Marne

  • Cohen Robert · Association Clinique Thérapeutique Infantile du val de Marne

Eligibility

Max Age
17 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-04-01
Primary Completion
2025-10-31
Completion
2025-12-19

Countries

  • France

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06036628 on ClinicalTrials.gov